Universal CAR T cells targeted with HER2-specific soluble linker penetrate spheroids and large tumour xenografts that are inherently resistant to trastuzumab-mediated ADCC

被引：0
|
作者：
Nagy, L. [1 ]
Mezosi-Csaplar, M. [1 ]
Rebenku, I. [1 ]
Vereb, G. [1 ,2 ,3 ]
Szoor, A. [1 ]
机构：
[1] Univ Debrecen, Dept Biophys & Cell Biol, Fac Med, Debrecen, Hungary
[2] Univ Debrecen, ELKH DE Cell Biol & Signalling Res Grp, Fac Med, Debrecen, Hungary
[3] Univ Debrecen, Fac Pharm, Debrecen, Hungary
来源：
HUMAN GENE THERAPY | 2024年 / 35卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P482
引用
收藏
页码：A211 / A211
页数：1
相关论文
共 4 条
  • [1] Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC
    Nagy, Lorinc
    Mezosi-Csaplar, Marianna
    Rebenku, Istvan
    Vereb, Gyorgy
    Szoor, Arpad
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies
    Szoor, Arpad
    Toth, Gabor
    Zsebik, Barbara
    Szabo, Viktoria
    Eshhar, Zelig
    Abken, Hinrich
    Vereb, Gyorgy
    CANCER LETTERS, 2020, 484 : 1 - 8
  • [3] Trastuzumab derived HER2-specific CAR for trastuzumab-resistant breast cancer: CAR T-cells successfully engage target epitopes that are not accessible to antibodies
    Szoor, A.
    Toth, G.
    Zsebik, B.
    Szabo, V.
    Eshhar, Z.
    Abken, H.
    Vereb, G.
    HUMAN GENE THERAPY, 2019, 30 (11) : A7 - A7
  • [4] EGFR-mediated alterations to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity (T-ADCC) in TKI-resistant HER2+breast cancer cell lines
    Gaynor, N.
    Canonici, A.
    Mcdermott, M.
    Crown, J.
    Collins, D.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E45 - E46
1